Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life

Frank Lehmann-Horn, Adele D'Amico, Enrico Bertini, Mauro Lomonaco, Luciano Merlini, Kevin R Nelson, Heike Philippi, Gabriele Siciliano, Frank Spaans, Karin Jurkat-Rott

Research output: Contribution to journalArticle

Abstract

Introduction: Myotonia permanens due to Nav1.4-G1306E is a rare sodium channelopathy with potentially life-threatening respiratory complications. Our goal was to study phenotypic variability throughout life.

Methods: Clinical neurophysiology and genetic analysis were performed. Using existing functional expression data we determined the sodium window by integration.

Results: In 10 unrelated patients who were believed to have epilepsy, respiratory disease or Schwartz-Jampel syndrome, we made the same prima facie diagnosis and detected the same heterologous Nav1.4-G1306E channel mutation as for our first myotonia permanens patient published in 1993. Eight mutations were de-novo, two were inherited from the affected parent each. Seven patients improved with age, one had a benign phenotype from birth, and two died of respiratory complications. The clinical features age-dependently varied with severe neonatal episodic laryngospasm in childhood and myotonia throughout life. Weakness of varying degrees was present. The responses to cold, exercise and warm-up were different for lower than for upper extremities. Spontaneous membrane depolarization increased frequency and decreased size of action potentials; self-generated repolarization did the opposite. The overlapping of steady-state activation and inactivation curves generated a 3.1-fold window area for G1306E vs. normal channels.

Discussion: Residue G1306 Neonatal laryngospasm and unusual distribution of myotonia, muscle hypertrophy, and weakness encourage direct search for the G1306E mutation, a hotspot for de-novo mutations. Successful therapy with the sodium channel blocker flecainide is due to stabilization of the inactivated state and special effectiveness for enlarged window currents. Our G1306E collection is the first genetically clarified case series from newborn period to adulthood and therefore helpful for counselling.

Original languageEnglish
Pages (from-to)125-134
Number of pages10
JournalActa Myologica
Volume36
Issue number3
Publication statusPublished - Sep 2017

Fingerprint

Laryngismus
Myotonia
Phenotype
Mutation
Warm-Up Exercise
Sodium
Channelopathies
Sodium Channel Blockers
Osteochondrodysplasias
Flecainide
Neurophysiology
Muscle Weakness
Hypertrophy
Action Potentials
Counseling
Lower Extremity
Epilepsy
Parturition
Newborn Infant
Membranes

Keywords

  • Action Potentials
  • Adolescent
  • Adult
  • Age Factors
  • Child
  • Child, Preschool
  • Dyspnea/etiology
  • Exercise/physiology
  • Female
  • Flecainide/therapeutic use
  • Heterozygote
  • Humans
  • Hypertrophy
  • Infant
  • Infant, Newborn
  • Laryngismus/etiology
  • Male
  • Middle Aged
  • Muscle Weakness/etiology
  • Mutation
  • Myotonia Congenita/complications
  • NAV1.4 Voltage-Gated Sodium Channel/genetics
  • Phenotype
  • Respiratory Sounds/etiology
  • Respiratory Tract Diseases/etiology
  • Voltage-Gated Sodium Channel Blockers/therapeutic use
  • Young Adult

Cite this

Lehmann-Horn, F., D'Amico, A., Bertini, E., Lomonaco, M., Merlini, L., Nelson, K. R., ... Jurkat-Rott, K. (2017). Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life. Acta Myologica, 36(3), 125-134.

Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life. / Lehmann-Horn, Frank; D'Amico, Adele; Bertini, Enrico; Lomonaco, Mauro; Merlini, Luciano; Nelson, Kevin R; Philippi, Heike; Siciliano, Gabriele; Spaans, Frank; Jurkat-Rott, Karin.

In: Acta Myologica, Vol. 36, No. 3, 09.2017, p. 125-134.

Research output: Contribution to journalArticle

Lehmann-Horn, F, D'Amico, A, Bertini, E, Lomonaco, M, Merlini, L, Nelson, KR, Philippi, H, Siciliano, G, Spaans, F & Jurkat-Rott, K 2017, 'Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life', Acta Myologica, vol. 36, no. 3, pp. 125-134.
Lehmann-Horn F, D'Amico A, Bertini E, Lomonaco M, Merlini L, Nelson KR et al. Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life. Acta Myologica. 2017 Sep;36(3):125-134.
Lehmann-Horn, Frank ; D'Amico, Adele ; Bertini, Enrico ; Lomonaco, Mauro ; Merlini, Luciano ; Nelson, Kevin R ; Philippi, Heike ; Siciliano, Gabriele ; Spaans, Frank ; Jurkat-Rott, Karin. / Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life. In: Acta Myologica. 2017 ; Vol. 36, No. 3. pp. 125-134.
@article{84738a44d93e426893a7752da83c826e,
title = "Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life",
abstract = "Introduction: Myotonia permanens due to Nav1.4-G1306E is a rare sodium channelopathy with potentially life-threatening respiratory complications. Our goal was to study phenotypic variability throughout life.Methods: Clinical neurophysiology and genetic analysis were performed. Using existing functional expression data we determined the sodium window by integration.Results: In 10 unrelated patients who were believed to have epilepsy, respiratory disease or Schwartz-Jampel syndrome, we made the same prima facie diagnosis and detected the same heterologous Nav1.4-G1306E channel mutation as for our first myotonia permanens patient published in 1993. Eight mutations were de-novo, two were inherited from the affected parent each. Seven patients improved with age, one had a benign phenotype from birth, and two died of respiratory complications. The clinical features age-dependently varied with severe neonatal episodic laryngospasm in childhood and myotonia throughout life. Weakness of varying degrees was present. The responses to cold, exercise and warm-up were different for lower than for upper extremities. Spontaneous membrane depolarization increased frequency and decreased size of action potentials; self-generated repolarization did the opposite. The overlapping of steady-state activation and inactivation curves generated a 3.1-fold window area for G1306E vs. normal channels.Discussion: Residue G1306 Neonatal laryngospasm and unusual distribution of myotonia, muscle hypertrophy, and weakness encourage direct search for the G1306E mutation, a hotspot for de-novo mutations. Successful therapy with the sodium channel blocker flecainide is due to stabilization of the inactivated state and special effectiveness for enlarged window currents. Our G1306E collection is the first genetically clarified case series from newborn period to adulthood and therefore helpful for counselling.",
keywords = "Action Potentials, Adolescent, Adult, Age Factors, Child, Child, Preschool, Dyspnea/etiology, Exercise/physiology, Female, Flecainide/therapeutic use, Heterozygote, Humans, Hypertrophy, Infant, Infant, Newborn, Laryngismus/etiology, Male, Middle Aged, Muscle Weakness/etiology, Mutation, Myotonia Congenita/complications, NAV1.4 Voltage-Gated Sodium Channel/genetics, Phenotype, Respiratory Sounds/etiology, Respiratory Tract Diseases/etiology, Voltage-Gated Sodium Channel Blockers/therapeutic use, Young Adult",
author = "Frank Lehmann-Horn and Adele D'Amico and Enrico Bertini and Mauro Lomonaco and Luciano Merlini and Nelson, {Kevin R} and Heike Philippi and Gabriele Siciliano and Frank Spaans and Karin Jurkat-Rott",
year = "2017",
month = "9",
language = "English",
volume = "36",
pages = "125--134",
journal = "Acta Myologica",
issn = "1128-2460",
publisher = "Gaetano Conte Academy",
number = "3",

}

TY - JOUR

T1 - Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life

AU - Lehmann-Horn, Frank

AU - D'Amico, Adele

AU - Bertini, Enrico

AU - Lomonaco, Mauro

AU - Merlini, Luciano

AU - Nelson, Kevin R

AU - Philippi, Heike

AU - Siciliano, Gabriele

AU - Spaans, Frank

AU - Jurkat-Rott, Karin

PY - 2017/9

Y1 - 2017/9

N2 - Introduction: Myotonia permanens due to Nav1.4-G1306E is a rare sodium channelopathy with potentially life-threatening respiratory complications. Our goal was to study phenotypic variability throughout life.Methods: Clinical neurophysiology and genetic analysis were performed. Using existing functional expression data we determined the sodium window by integration.Results: In 10 unrelated patients who were believed to have epilepsy, respiratory disease or Schwartz-Jampel syndrome, we made the same prima facie diagnosis and detected the same heterologous Nav1.4-G1306E channel mutation as for our first myotonia permanens patient published in 1993. Eight mutations were de-novo, two were inherited from the affected parent each. Seven patients improved with age, one had a benign phenotype from birth, and two died of respiratory complications. The clinical features age-dependently varied with severe neonatal episodic laryngospasm in childhood and myotonia throughout life. Weakness of varying degrees was present. The responses to cold, exercise and warm-up were different for lower than for upper extremities. Spontaneous membrane depolarization increased frequency and decreased size of action potentials; self-generated repolarization did the opposite. The overlapping of steady-state activation and inactivation curves generated a 3.1-fold window area for G1306E vs. normal channels.Discussion: Residue G1306 Neonatal laryngospasm and unusual distribution of myotonia, muscle hypertrophy, and weakness encourage direct search for the G1306E mutation, a hotspot for de-novo mutations. Successful therapy with the sodium channel blocker flecainide is due to stabilization of the inactivated state and special effectiveness for enlarged window currents. Our G1306E collection is the first genetically clarified case series from newborn period to adulthood and therefore helpful for counselling.

AB - Introduction: Myotonia permanens due to Nav1.4-G1306E is a rare sodium channelopathy with potentially life-threatening respiratory complications. Our goal was to study phenotypic variability throughout life.Methods: Clinical neurophysiology and genetic analysis were performed. Using existing functional expression data we determined the sodium window by integration.Results: In 10 unrelated patients who were believed to have epilepsy, respiratory disease or Schwartz-Jampel syndrome, we made the same prima facie diagnosis and detected the same heterologous Nav1.4-G1306E channel mutation as for our first myotonia permanens patient published in 1993. Eight mutations were de-novo, two were inherited from the affected parent each. Seven patients improved with age, one had a benign phenotype from birth, and two died of respiratory complications. The clinical features age-dependently varied with severe neonatal episodic laryngospasm in childhood and myotonia throughout life. Weakness of varying degrees was present. The responses to cold, exercise and warm-up were different for lower than for upper extremities. Spontaneous membrane depolarization increased frequency and decreased size of action potentials; self-generated repolarization did the opposite. The overlapping of steady-state activation and inactivation curves generated a 3.1-fold window area for G1306E vs. normal channels.Discussion: Residue G1306 Neonatal laryngospasm and unusual distribution of myotonia, muscle hypertrophy, and weakness encourage direct search for the G1306E mutation, a hotspot for de-novo mutations. Successful therapy with the sodium channel blocker flecainide is due to stabilization of the inactivated state and special effectiveness for enlarged window currents. Our G1306E collection is the first genetically clarified case series from newborn period to adulthood and therefore helpful for counselling.

KW - Action Potentials

KW - Adolescent

KW - Adult

KW - Age Factors

KW - Child

KW - Child, Preschool

KW - Dyspnea/etiology

KW - Exercise/physiology

KW - Female

KW - Flecainide/therapeutic use

KW - Heterozygote

KW - Humans

KW - Hypertrophy

KW - Infant

KW - Infant, Newborn

KW - Laryngismus/etiology

KW - Male

KW - Middle Aged

KW - Muscle Weakness/etiology

KW - Mutation

KW - Myotonia Congenita/complications

KW - NAV1.4 Voltage-Gated Sodium Channel/genetics

KW - Phenotype

KW - Respiratory Sounds/etiology

KW - Respiratory Tract Diseases/etiology

KW - Voltage-Gated Sodium Channel Blockers/therapeutic use

KW - Young Adult

M3 - Article

C2 - 29774303

VL - 36

SP - 125

EP - 134

JO - Acta Myologica

JF - Acta Myologica

SN - 1128-2460

IS - 3

ER -